IN8bio's total assets for Q2 2025 were $19.37M, a decrease of -2.51% from the previous quarter. INAB total liabilities were $4.13M for the fiscal quarter, a -31.04% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.